Buspirone for Early Satiety and Symptoms of Gastroparesis

PHASE2CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

August 27, 2019

Primary Completion Date

April 15, 2022

Study Completion Date

April 30, 2022

Conditions
Gastroparesis
Interventions
DRUG

Buspirone

Buspirone tablet

DRUG

Placebo

"Sugar pill manufactured to mimic buspirone 10 mg tablet"

Trial Locations (6)

19140

Temple University, Philadelphia

21287

Johns Hopkins Hospital, Baltimore

27157

Wake Forest University Health Sciences, Winston-Salem

40202

University of Louisville, Louisville

79905

Texas Tech University Health Science Center, El Paso

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Texas Tech University Health Sciences Center, El Paso

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

Temple University

OTHER

collaborator

University of Louisville

OTHER

collaborator

Wake Forest University

OTHER

collaborator

Massachusetts General Hospital

OTHER

lead

Johns Hopkins Bloomberg School of Public Health

OTHER

NCT03587142 - Buspirone for Early Satiety and Symptoms of Gastroparesis | Biotech Hunter | Biotech Hunter